Virtus Investment Advisers’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$411K Buy
11,311
+3,656
+48% +$133K 0.14% 224
2025
Q1
$277K Buy
+7,655
New +$277K 0.08% 246